Mobile Menu

Search Results

Search results for: TP53

LSD1 promotes prostate cancer cell reprogramming through TP53 repression

Prostate cancers are generally treatable with positive survival outcomes. However, following common treatments such as androgen receptor inhibitors, some prostate […]

Key cross-species genes offer insight into human bladder cancer development

Muscle invasive bladder cancer (MIBC) is an aggressive form of human bladder cancer. Little is currently known about the genetic […]

Five New Genes Linked to Breast Cancer 

An international collaborative research paper published last week in Nature Genetics has identified several new genes associated with breast cancer […]

UK’s Higher Skin Cancer Rates Defy UV Index

A recent collaboration between the Wellcome Sanger Institute and the Skin Research Institute of Singapore (SRIS) has been published in […]

AI speeds up brain tumour profiling

‘AI speeds up brain tumour profiling‘ – Written by Charlotte Harrison, Science Writer  A team, led by Harvard Medical School […]

Insights into a new drug for non-Hodgkin’s lymphoma

‘Insights into a new drug for non-Hodgkin’s lymphoma’ – Written by Charlotte Harrison, Science Writer. A team of researchers from […]

Transcriptional-translational conflict prevents tumour progression in bladder cancer

The process of transcriptional-translational conflict has been defined in a recent paper, published in Cancer Cell. This represents a new […]

Multi-omics approach reveals mechanisms of proliferation control in cancer

In a recent paper, published in Science, researchers used a multi-omics approach to identify peptides, transcripts, and phosphorylation events and […]

Rapid genetic screening in neurological disorders using CRISPR

Written by Liam Little, Science Writer A recent article, published in Nature Neuroscience, aimed to understand the emerging roles of […]

Clinical and Genomic Profiles of Black Patients with Prostate Cancer

Written by Sharmin Begum, science writer  Black patients who were diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), have been analysed […]